Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Visa Inc (V) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Visa Inc vs Health Care Select Sector SPDR Fund — how do they compare? Visa Inc trades at $362.12 (market cap $671.74B), while Health Care Select Sector SPDR Fund trades at $167.38. The key difference: Visa Inc pays a 0.74% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.

VXLV
Market Cap
$671.74B
Volume
10,431,336
Sector
Financials
52-Week High
$370.47$168.44
52-Week Low
$295.52$131.16
Enterprise Value
$682.32B
Dividend Yield
0.74%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Visa Inc

Visa (V) trades at $361.32, down 0.33% on the day, with a bearish technical signal but strong fundamentals. The stock shows consistent earnings beats, with Q2 2026 EPS of $3.32 exceeding the $3.23 estimate. Revenue grew to $40 billion in 2025, with a net income margin of 50.78%. Recent news highlights Visa's AI initiatives, such as Intelligent Commerce Connect, to enhance payment efficiency.

The outlook remains positive due to high analyst buy ratings (85.48%) and a consensus price target of $426.31, implying 18% upside. Risks include fintech competition and regulatory pressures, but Visa's robust cash flow and profitability support long-term growth potential for investors.

Health Care Select Sector SPDR Fund

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Visa Inc

Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.

Read more on V

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV